Factors Influencing Overall Survival of Children, Adolescents, and Young Adults With High-risk Renal Tumors

被引:4
作者
Islam, Majdee
Saltzman, Amanda F.
Amini, Arya
Carrasco, Alonso, Jr.
Cost, Nicholas G.
机构
[1] Univ Colorado, Div Urol, Dept Surg, Aurora, CO 80045 USA
[2] Childrens Hosp Colorado, Aurora, CO USA
[3] Univ Colorado, Dept Radiat Oncol, Aurora, CO 80045 USA
关键词
CLEAR-CELL SARCOMA; NATIONAL WILMS-TUMOR; RHABDOID TUMOR; KIDNEY;
D O I
10.1016/j.urology.2018.07.032
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE To identity tactors impacting overall survival tOS) in children, adolescents, and young adults with high-risk renal tumors (HRRTs). METHODS The National Cancer Database was queried for patients <= 30 years old diagnosed with anaplastic Wilms tumors (AWT), clear cell sarcoma of the kidney (CCSK), or rhabdoid tumor of the kidney (RTK) between 2004 and 2013. Demographic, clinical, and OS data were abstracted. OS between groups was compared with a Kaplan-Meier curve. Univariate and multivariate survival analyses were performed. RESULTS A total of 349 patients were identified meeting criteria; 133 (38.1%) AWT, 120 (34.4%) CCSK, and 96 (27.5%) RTK. Patients with RTK were less likely to undergo surgery than those with AWT or CCSK (77.1% vs 94% vs 99%, P < .001) and less likely to receive chemotherapy (84.4% vs 96.2% vs 95%, P = .013) or radiation (52.1% vs 81.2% vs 86.7%, P < .001). Estimated 5-year OS was 76.1% (95% confidence interval [CI] 67.9-84.4) for AWT, 92.7% (95% CI 87.4-97.9) for CCSK, and 33.5% (95% CI 23.1-43.9) for RTK (P < .001). On multivariate analysis, AWT (HR 3.372, P = .032) and RTK histology (HR 12.595, P < .001) were significantly associated with worse OS, while receiving radiation (HR 0.43, P = .006) was associated with improved OS. LN positivity, margin status, and undergoing surgery were not. Analyzing the HRRTs individually, for AWT, undergoing surgery was associated with OS (HR 0.308, P = .031). For RTK, factors associated with OS included undergoing surgery (HR 0.209, P = .007) and radiation (HR 0.411, P = .008). CONCLUSION Within the HRRTs, RTK is associated with worse outcomes than either AWT or CCSK. Receiving radiation is significantly associated with improved outcomes, and surgery is important for those with AWT and RTK. (C) 2018 Elsevier Inc.
引用
收藏
页码:222 / 230
页数:9
相关论文
共 29 条
[1]  
American Cancer Society, 2016, WILMS TUM, P1
[2]  
[Anonymous], CHILDRENS ONCOLOGY G
[3]   Clear cell sarcoma of the kidney - A review of 351 cases from the National Wilms Tumor Study Group Pathology Center [J].
Argani, P ;
Perlman, EJ ;
Breslow, NE ;
Browning, NG ;
Green, DM ;
D'Angio, GJ ;
Beckwith, JB .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2000, 24 (01) :4-18
[4]   Clear cell sarcoma of the pediatric kidney: Detailed description and analysis of variant histologic patterns of a tumor with many faces [J].
Balarezo, FS ;
Joshi, VV .
ADVANCES IN ANATOMIC PATHOLOGY, 2001, 8 (02) :98-108
[5]  
Biegel JA, 1999, CANCER RES, V59, P74
[6]   Treatment of anaplastic histology Wilms' tumor: Results from the fifth National Wilms' Tumor Study [J].
Dome, Jeffrey S. ;
Cotton, Cecilia A. ;
Perlman, Elizabeth J. ;
Breslow, Norman E. ;
Kalapurakal, John A. ;
Ritchey, Michael L. ;
Grundy, Paul E. ;
Malogolowkin, Marcio ;
Beckwith, J. Bruce ;
Shamberger, Robert C. ;
Haase, Gerald M. ;
Coppes, Max J. ;
Coccia, Peter ;
Kletzel, Morris ;
Weetman, Robert M. ;
Donaldson, Milton ;
Macklis, Roger M. ;
Green, Daniel M. .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (15) :2352-2358
[7]   Children's Oncology Group's 2013 blueprint for research: Renal tumors [J].
Dome, Jeffrey S. ;
Fernandez, Conrad V. ;
Mullen, Elizabeth A. ;
Kalapurakal, John A. ;
Geller, James I. ;
Huff, Vicki ;
Gratias, Eric J. ;
Dix, David B. ;
Ehrlich, Peter F. ;
Khanna, Geetika ;
Malogolowkin, Marcio H. ;
Anderson, James R. ;
Naranjo, Arlene ;
Perlman, Elizabeth J. .
PEDIATRIC BLOOD & CANCER, 2013, 60 (06) :994-1000
[8]  
Fernandez C, 2011, PRINCIPLES PRACTICE, P861
[9]  
Furtwangler R, 2014, CANC GENET, V207, P434
[10]  
Furtwangler R, 2018, PEDIAT BLOOD CANC, P65